The effects of glaucoma on the latency of the multifocal visual evoked potential.

Evaluation of the visual function in obstructive sleep apnea syndrome patients and normal-tension glaucoma by means of the multifocal visual evoked potentials. Graefes Arch Clin Exp Ophthalmol (2012) 2.05

Multifocal VEP and OCT findings in patients with primary open angle glaucoma: a cross-sectional study. BMC Ophthalmol (2012) 0.86

Statistical test of VEP waveform equality. Doc Ophthalmol (2009) 0.79

Evaluation of multifocal visual evoked potentials in patients with Graves' orbitopathy and subclinical optic nerve involvement. Doc Ophthalmol (2012) 0.76

The role of the multifocal visual evoked potential (mfVEP) latency in understanding optic nerve and retinal diseases. Trans Am Ophthalmol Soc (2006) 0.75

Latency of the mfVEP to diagnose glaucoma? Br J Ophthalmol (2006) 0.75

All in the timing. Br J Ophthalmol (2007) 0.75

Evaluation of hemifield sector analysis protocol in multifocal visual evoked potential objective perimetry for the diagnosis and early detection of glaucomatous field defects. Korean J Ophthalmol (2014) 0.75

The effects of glaucoma on the latency of the multifocal visual evoked potential. Br J Ophthalmol (2006) 0.75

Visual Evoked Potentials in Primary Open Angle Glaucoma. J Neurodegener Dis (2017) 0.75

Exploring the methods of data analysis in multifocal visual evoked potentials. Doc Ophthalmol (2016) 0.75

Multifocal VEP and ganglion cell damage: applications and limitations for the study of glaucoma. Prog Retin Eye Res (2003) 2.67

The topography of visual evoked response properties across the visual field. Electroencephalogr Clin Neurophysiol (1994) 2.27

An interocular comparison of the multifocal VEP: a possible technique for detecting local damage to the optic nerve. Invest Ophthalmol Vis Sci (2000) 1.88

Multifocal objective perimetry in the detection of glaucomatous field loss. Am J Ophthalmol (2002) 1.68

Multifocal topographic visual evoked potential: improving objective detection of local visual field defects. Invest Ophthalmol Vis Sci (1998) 1.64

Quantifying the benefits of additional channels of multifocal VEP recording. Doc Ophthalmol (2002) 1.57

Detecting early to mild glaucomatous damage: a comparison of the multifocal VEP and automated perimetry. Invest Ophthalmol Vis Sci (2004) 1.56

Normative ranges and specificity of the multifocal VEP. Doc Ophthalmol (2004) 1.52

A signal-to-noise analysis of multifocal VEP responses: an objective definition for poor records. Doc Ophthalmol (2002) 1.45

Objective VEP perimetry in glaucoma: asymmetry analysis to identify early deficits. J Glaucoma (2000) 1.42

Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma. Ophthalmology (2006) 1.32

Clinical application of objective perimetry using multifocal visual evoked potentials in glaucoma practice. Arch Ophthalmol (2005) 1.24

Determining abnormal latencies of multifocal visual evoked potentials: a monocular analysis. Doc Ophthalmol (2004) 1.23

The visual evoked potential in glaucoma and ocular hypertension: effects of check size, field size, and stimulation rate. Invest Ophthalmol Vis Sci (1983) 1.15

Multifocal visual evoked potential responses in glaucoma patients with unilateral hemifield defects. Am J Ophthalmol (2003) 1.12

Impaired visual function in glaucoma. Clin Neurophysiol (2001) 1.07

Determining abnormal interocular latencies of multifocal visual evoked potentials. Doc Ophthalmol (2004) 1.05

Mapping of glaucomatous visual field defects by multifocal VEPs. Invest Ophthalmol Vis Sci (2001) 0.93

Oral citicoline treatment improves visual pathway function in glaucoma. Med Sci Monit (2003) 0.92

Flicker threshold and pattern VEP latency in ocular hypertension and glaucoma. Invest Ophthalmol Vis Sci (1983) 0.90

Neural conduction in the visual pathways in ocular hypertension and glaucoma. Graefes Arch Clin Exp Ophthalmol (1997) 0.81

Identification of a gene that causes primary open angle glaucoma. Science (1997) 8.14

Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet (1999) 3.24

Ultrasound biomicroscopy in pigment dispersion syndrome. Ophthalmology (1994) 2.98

Prevent Blindness America visual field screening study. The Prevent Blindness America Glaucoma Advisory Committee. Am J Ophthalmol (1995) 2.88

Dysfunction of early-stage visual processing in schizophrenia. Am J Psychiatry (2001) 2.80

Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. Ophthalmology (2000) 2.70

Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet (1998) 2.34

Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol (1997) 2.31

Factors affecting image acquisition during scanning laser polarimetry. Ophthalmic Surg Lasers (1998) 2.23

Prevention of blinking alters iris configuration in pigment dispersion syndrome and in normal eyes. Ophthalmology (1995) 2.21

Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol (2000) 2.13

Imaging congenital optic disc pits and associated maculopathy using optical coherence tomography. Arch Ophthalmol (1996) 1.94

Structural and functional assessment of the macular region in patients with glaucoma. Br J Ophthalmol (2006) 1.92

Racial differences in optic nerve head parameters. Arch Ophthalmol (1989) 1.92

An interocular comparison of the multifocal VEP: a possible technique for detecting local damage to the optic nerve. Invest Ophthalmol Vis Sci (2000) 1.88

Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man. Proc Natl Acad Sci U S A (1998) 1.75

Prevalence of pigment dispersion syndrome in a population undergoing glaucoma screening. Am J Ophthalmol (1993) 1.71

Ultrasound biomicroscopy in plateau iris syndrome. Am J Ophthalmol (1992) 1.70

Late infectious endophthalmitis from exposed glaucoma setons. Arch Ophthalmol (1992) 1.58

Photoresponses of human rods in vivo derived from paired-flash electroretinograms. Vis Neurosci (1997) 1.57

Abnormal activation and inactivation mechanisms of rod transduction in patients with autosomal dominant retinitis pigmentosa and the pro-23-his mutation. Invest Ophthalmol Vis Sci (1995) 1.56

Age-related decline of disc rim area in visually normal subjects. Ophthalmology (1992) 1.55

Heidelberg retina tomography and optical coherence tomography in normal, ocular-hypertensive, and glaucomatous eyes. Ophthalmology (1999) 1.53

New patterns of infecting organisms in late bleb-related endophthalmitis: a ten year review. Eye (Lond) (1998) 1.53

Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology (1991) 1.52

S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci (1989) 1.50

Measurement of ultrasound biomicroscopy images: intraobserver and interobserver reliability. Invest Ophthalmol Vis Sci (1994) 1.50

Quantitative assessment of the anterior segment using ultrasound biomicroscopy. Curr Opin Ophthalmol (2000) 1.50

Initial 5-fluorouracil trabeculectomy in uncomplicated glaucoma. Ophthalmology (1991) 1.50

Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol (1998) 1.48

Reproducibility of retinal thickness measurements in normal eyes using optical coherence tomography. Ophthalmic Surg Lasers (1998) 1.47

The Glaucoma Symptom Scale. A brief index of glaucoma-specific symptoms. Arch Ophthalmol (1998) 1.46

Ultrasound biomicroscopy in pseudophakic malignant glaucoma. Ophthalmology (1993) 1.46

Bleb-related ocular infection in children after trabeculectomy with mitomycin C. Ophthalmology (1997) 1.46

Combined phacoemulsification and goniosynechialysis for uncontrolled chronic angle-closure glaucoma after acute angle-closure glaucoma. Ophthalmology (1999) 1.42

Shades of gray matter: noninvasive optical images of human brain responses during visual stimulation. Psychophysiology (1995) 1.41

Soft contact lens modification of the ocular cup for high-resolution ultrasound biomicroscopy. Ophthalmic Surg (1993) 1.40

Congenital ectropion uveae with glaucoma. Ophthalmology (1984) 1.37

Intraocular suture ligature to reduce hypotony following Molteno seton implantation. Ophthalmic Surg (1992) 1.37

Recovery of cone receptor activity in the frog's isolated retina. Vision Res (1973) 1.35

Synaptic activity of frog retinal photoreceptors. A peroxidase uptake study. J Cell Biol (1976) 1.35

Pericardial patch grafts in glaucoma implant surgery. J Glaucoma (1998) 1.30

Exfoliation syndrome and occludable angles. Trans Am Ophthalmol Soc (1994) 1.30

Clinical signs of the pseudoexfoliation syndrome. Ophthalmology (1986) 1.29

Treatment of the Weill-Marchesani syndrome. Ann Ophthalmol (1981) 1.29

Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. J Infect Dis (1999) 1.28

Optical coherence tomography and scanning laser polarimetry in normal, ocular hypertensive, and glaucomatous eyes. Am J Ophthalmol (2000) 1.27

Ocular findings in oculodermal melanocytosis. Arch Ophthalmol (1990) 1.26

Increase in iris-lens contact after laser iridotomy for pupillary block angle closure. Am J Ophthalmol (1996) 1.25

Preclinical diagnosis of pseudoexfoliation syndrome. Arch Ophthalmol (1987) 1.25

Optic coherence tomography of optic disk pit maculopathy. Am J Ophthalmol (1996) 1.23

Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci Lett (2001) 1.21

Argon laser peripheral iridoplasty. Ophthalmic Surg Lasers (1996) 1.19

Effect of a tight necktie on intraocular pressure. Br J Ophthalmol (2003) 1.19

Differential diagnosis of anterior segment cysts by ultrasound biomicroscopy. Ophthalmology (1999) 1.18

A comparison between microperimetry and standard achromatic perimetry of the central visual field in eyes with glaucomatous paracentral visual-field defects. Br J Ophthalmol (2009) 1.17

Ultrasound biomicroscopy dark room provocative testing: a quantitative method for estimating anterior chamber angle width. Jpn J Ophthalmol (2000) 1.17

Comparisons of anterior segment biometry between Chinese and Caucasians using anterior segment optical coherence tomography. Br J Ophthalmol (2010) 1.13

Diode laser transscleral cyclophotocoagulation for refractory glaucoma. J Glaucoma (2001) 1.13

Retinal nerve fibre thickness measured with optical coherence tomography accurately detects confirmed glaucomatous damage. Br J Ophthalmol (2007) 1.12

Continuous wave argon laser iridectomy in angle-closure glaucoma. Am J Ophthalmol (1979) 1.12

Peripapillary nerve fiber layer thickness measurement reproducibility using scanning laser polarimetry. J Glaucoma (1998) 1.12

Pseudotumor cerebri appearing with unilateral papilledema after trabeculectomy. Arch Ophthalmol (1997) 1.11

Axial length and optic disc size in normal eyes. Br J Ophthalmol (2006) 1.11

Progressive cone dystrophy. Ophthalmology (1987) 1.11

Filtering valve implant surgery for eyes wtih neovascular glaucoma. Am J Ophthalmol (1980) 1.11

Glaucoma in phakomatosis pigmentovascularis. Ophthalmology (1997) 1.11